🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted steps to deal with cost of living pressures" in the upcoming Budget.

During an interview with the BBC, she noted that lowering inflation is a collective responsibility of both the government and the central bank.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Potential Energy Cost Interventions

Sources suggest the administration could take action to lower utility costs, for example by slashing the present 5% level of value-added tax applied on energy.

Another possibility is to lower some of the government charges presently included in bills.

Fiscal Constraints and Expert Predictions

The administration will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for such measures.

The consensus from the majority of economists is that Reeves will have to announce tax rises or spending cuts in order to adhere to her voluntary borrowing rules.

Earlier on Thursday, analysis suggested there was a £22bn shortfall for the Treasury chief to resolve, which is at the lower end of projections.

"It is a collective responsibility between the central bank and the government to continue tackling some of the sources of inflation," the Chancellor informed the BBC in Washington, at the annual meetings of the IMF and global financial institution.

Tax Pledges and International Issues

While a great deal of the focus has been on expected tax increases, the chancellor said the latest information from the OBR had not altered her vow to manifesto promises not to raise tax levels on income tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with growing geopolitical and trade issues for the Budget revenue measures, probably to be directed on those "with the broadest shoulders."

Global Trade Tensions

Referring to concerns about the United Kingdom's trade ties with China she said: "Our national security always come first."

Recent declaration by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are crucial for high-technology production led American leader the US President to propose an extra 100% tariff on imports from China, increasing the risk of an all-out commercial conflict between the two global powers.

The American finance chief described China's action "commercial pressure" and "a international production control attempt."

Questioned on considering the American proposal to join its battle with China, the Chancellor said she was "very concerned" by Chinese actions and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the action was "bad for the international commerce and causes additional headwinds."

"I believe there are sectors where we need to address China, but there are also significant chances to export to China's economy, including financial services and other sectors of the economic system. We've got to achieve that balance appropriate."

The chancellor also confirmed she was collaborating with other major economies "on our own critical minerals strategy, so that we are reduced dependence."

Health Service Medicine Costs and Funding

Reeves also recognized that the price the NHS spends on pharmaceuticals could increase as a consequence of ongoing talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding.

A number of the biggest global drug companies have said in recent statements that they are either pausing or abandoning operations in the UK, with several attributing the low prices they are receiving.

Recently, the government science advisor said the price the health service pays for medicines would need to rise to prevent companies and drug research funding departing from the United Kingdom.

Reeves stated to the BBC: "We have seen due to the pricing regime, that medical research, new drugs have not been available in the UK in the extent that they are in other EU nations."

"The objective is to make sure that patients getting care from the National Health Service are can receive the top essential medicines in the world. And so we are looking at these issues, and... aiming to obtain increased investment into Britain."